Evidence map›Paper›PMID 42574627›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Illegal markets for cigarettes and e-cigarettes.

Donald Kenkel, Grace Phillips

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. A budding science of illegal markets.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. The policy construction of illegal markets: Exploring variation, success, failure, and unintended consequences.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Illegal markets: An important domain for applied science.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Donald KenkelDepartment of Economics, Jeb E. Brooks School of Public Policy, Cornell University, Ithaca, NY 14853.ORCID 0000-0002-9032-8477
Grace PhillipsDepartment of Economics, University of Memphis, Memphis, TN 38152.ORCID 0000-0001-8641-0462

Funding

Global Action to End Smoking none
6 · The paper itself

Abstract

This paper discusses the long-standing illegal markets for cigarettes and the more recently emerged illegal markets for e-cigarettes. We identify three distinctive market fundamentals that help explain many features of the illegal markets. First, in contrast to some illegal goods, many countries have sizable legal markets for cigarettes and e-cigarettes alongside the illegal markets. In 2024, tobacco products generated almost $1 trillion in revenues; e-cigarettes generated $26 billion dollars. It is estimated that illegal markets account for about 10 percent of global cigarette consumption. Second, the illegal markets have arisen to evade high excise taxes that increase prices and regulations that restrict the availability of desirable features of legal products. The taxes and regulations have been adopted as public health measures with the goal of reducing tobacco consumption; however, these same policies drive the formation of illegal markets. Third, demand-side linkages mean that taxation, regulatory, and enforcement policies targeted at legal and illegal markets for cigarettes will affect legal and illegal markets for e-cigarettes, and vice versa. The connection between the markets means regulatory policy for one product can drive consumers both to the illegal market for the product and to the legal and illegal market for the other product.

Indexed as

CommerceElectronic Nicotine Delivery SystemsTobacco ProductsHumansTaxesTobacco Controlcigarettese-cigarettesillegal markets

Identifiers

PMID42574627
PMCPMC13486574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.